U.S. Women’s Health Diagnostics Market – Industry Trends and Forecast to 2030

Women’s Health Diagnostics Market Analysis and Size

Women's health is the branch of medicine that mainly focuses on the treatment and diagnosis of diseases and conditions that affect a woman's health. Women's health diagnostic method includes screening, testing, or diagnosing, and monitoring of several women-related disorders, such as breast cancer, ovarian cancer, cervical cancer, menopause, and pregnancy. Different types of test are available for the diagnosis women health-related diseases. The medical diagnostics devices, such as biopsy device, imaging & monitoring system, mammography system, and other detect cancer, remove blockages, and capture the images of internal organs help for screening & diagnosis of disease. The diagnostic test includes breast cancer testing, cervical cancer testing, prenatal genetic screening & carrier testing, pregnancy, ovulation testing and ovarian cancer testing. The use of tests for screening and detection of various disorders is necessary to prevent complications and improve quality of life. Health tests are vital for improving health and preventing and treating serious diseases.                                

Data Bridge Market Research analyses that the women’s health diagnostics market which was USD 5,962.00 million in 2023, would rocket up to USD 11,462.00 million by 2030, and is expected to undergo a CAGR of 8.5% during the forecast period. This indicates that the market value. “Imaging and Monitoring Systems” dominates the diagnostic devices segment of the women’s health diagnostics market owing to the increase in incidence of chronic and lifestyle disorders. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Women’s Health Diagnostics Market Scope and Segmentation

​​​​​​​

Market Definition

The U.S. women's health diagnostic market refers to the healthcare industry segment focused on developing, manufacturing, and distributing medical diagnostic tests and devices specifically designed for assessing and monitoring women's health conditions. These diagnostic tests and devices are used by healthcare professionals to detect, diagnose, and manage various diseases and conditions that primarily affect women, including reproductive health issues, gynaecological disorders, breast cancer, cervical cancer, menopause-related conditions, and other female-specific health concerns.

Women’s Health Diagnostics Market Dynamics

Drivers

• Increasing Awareness And Focus On Women's Health

There has been a significant rise in public awareness and recognition of women's health issues, leading to the increased demand for diagnostic tests and screenings. The government initiatives, advocacy campaigns, and educational efforts have played a crucial role in emphasizing the importance of early detection and prevention of women's health conditions. This in turn has carved the way for the growth of the market.

• Shift Towards Preventive Healthcare

There is a growing emphasis on preventive healthcare, including regular screenings and early detection of diseases. Women's health diagnostics enable early identification of risk factors, allowing healthcare providers to implement preventive measures and personalized treatment plans. This focus on prevention contributes to the growth of the market.

• Increasing Research And Development Activities

Ongoing research and development efforts in the field of women's health diagnostics lead to the introduction of innovative technologies, tests, and devices. This drives market growth by expanding the range of diagnostic options available and improving their accuracy, reliability, and accessibility.  

Opportunities

• Advancements in Diagnostic Technologies

Rapid advancements in medical technologies, such as molecular diagnostics, next-generation sequencing, imaging modalities, and point-of-care testing, have revolutionized the field of women's health diagnostics. These innovations have led to more accurate, sensitive, and efficient diagnostic tools, enabling early detection, personalized treatment strategies, and improved patient outcomes. Thus, advancements in diagnostic technologies is expected to act as an opportunity for the growth of market.

Restraints/Challenges

• High cost of diagnostics procedure

The cost of diagnostic tests and devices can be a barrier to access for certain segments of the population. High costs may limit the adoption of advanced diagnostic technologies and screening programs, particularly among uninsured or underinsured individuals. Addressing affordability concerns is crucial to ensure equitable access to women's health diagnostics. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, heavy custom duty imposed on the medical devices, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2023-2030.

This women’s health diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the women’s health diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In April 2023, Quest Diagnostics and NewYork-Presbyterian, announced that Quest hadcompleted its previously announced acquisition of select assets of the laboratory services business of NewYork-Presbyterian. The goal of the collaboration is to enable providers and patients to access high quality, affordable testing from a service menu that combines the complementary strengths of both organizations
• In March 2023, F. Hoffmann-La Roche Ltd announced that it had entered into a collaboration with Eli Lilly and Company to support the development of Roche’s Elecsys Amyloid Plasma Panel (EAPP). The EAPP is an innovative blood test that aims to facilitate the earlier diagnosis of Alzheimer’s disease

U.S. Women’s Health Diagnostics Market Scope

The women’s health diagnostics market is segmented on the basis of diagnostic devices, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Diagnostic Devices

• Imaging and Monitoring Systems
• Biopsy Devices
• Reagents and Kits
• Biomarkers
• Others

Application

• Osteoporosis Testing
• OVC Testing
• Cervical Cancer Testing
• Breast Cancer Testing
• Pregnancy and Fertility Testing
• Prenatal Genetic Screening and Carrier Testing
• Infectious Disease Testing
• STD Testing
• Ultrasound Tests

End User

• Hospitals
• Diagnostic and Imaging Centres
• Clinics and Home Care Setting

Women’s Health Diagnostics Market Regional Analysis/Insights

The women’s health diagnostics market is analyzed and market size insights and trends are provided by country, diagnostic devices, application, and end user as referenced above.

The countries covered in the women’s health diagnostics market report is U.S.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The women’s health diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for women’s health diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the women’s health diagnostics market. The data is available for historic period 2010-2020.

Competitive Landscape and Women’s health diagnostics Market Share Analysis

The women’s health diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to women’s health diagnostics market.

Some of the major players operating in the women’s health diagnostics market are:

• bioMérieux SA
• Carestream Health
• MEDGYN PRODUCTS, INC.
• COOK
• Cardinal Health
• PerkinElmer Inc.
• GENERAL ELECTRIC
• Quest Diagnostics Incorporated
• Sysmex Corporation
• Siemens
• Hologic Inc.
• Abbott
• BD
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Koninklijke Philips N.V.
• NeuroLogica Corp.
• Danaher
• FUJIFILM Holdings Corporation
• Hitachi, Ltd.
• Canon Inc.

SKU-44685